These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2199953)
61. The diagnosis and treatment of impotence. Impotence Study Group of Western Australia. Med J Aust; 1988 May; 148(10):494-8. PubMed ID: 3367817 [TBL] [Abstract][Full Text] [Related]
62. [Measuring nocturnal tumescence--value in diagnosis of impotence]. Suter S; John H Ther Umsch; 1998 Jun; 55(6):361-4. PubMed ID: 9658977 [TBL] [Abstract][Full Text] [Related]
63. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence]. Martin-du Pan R Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216 [No Abstract] [Full Text] [Related]
64. [Action of vasoactive drugs in male sexual impotence]. Morales JC; Elizondo B Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491 [TBL] [Abstract][Full Text] [Related]
65. Evaluation of treatment of impotence--where are we going? Lue TF West J Med; 1985 Apr; 142(4):546. PubMed ID: 4013267 [No Abstract] [Full Text] [Related]
67. Summaries for patients. Hormonal testing and pharmacologic treatment of erectile dysfunction. Ann Intern Med; 2009 Nov; 151(9):I-44. PubMed ID: 19884619 [No Abstract] [Full Text] [Related]
68. Evaluation of the first 70 patients in the center for male sexual dysfunction of Beth Israel Medical Center. Melman A; Kaplan D; Redfield J J Urol; 1984 Jan; 131(1):53-5. PubMed ID: 6690747 [TBL] [Abstract][Full Text] [Related]
69. An intermediate approach to impotence evaluation. Melman A Contemp Urol; 1995 Jul; 7(7):14-8, 21. PubMed ID: 10150576 [No Abstract] [Full Text] [Related]
70. [Trial of intracavernous papaverine in the treatment of impotence. Therapeutic prospects]. Virag R; Virag H J Mal Vasc; 1983; 8(4):293-5. PubMed ID: 6663198 [TBL] [Abstract][Full Text] [Related]
71. [The value of using a facilitating dose of papaverine chlorhydrate during cavernometry]. Amer M; Lorge F; Schouman M; Arvis G Ann Urol (Paris); 1991; 25(1):25-9. PubMed ID: 2021270 [TBL] [Abstract][Full Text] [Related]
73. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Levine LA; Lenting EL Urol Clin North Am; 1995 Nov; 22(4):775-88. PubMed ID: 7483128 [TBL] [Abstract][Full Text] [Related]
74. [Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases]. Salinas Casado J; Vírseda Chamorro M; Samblas García R; Esteban Fuertes M; Aristizábal Agudelo JM; Blázquez Izquierdo J; Delgado Martín JA; Resel Estévez L Arch Esp Urol; 1996 Oct; 49(8):849-57. PubMed ID: 9065283 [TBL] [Abstract][Full Text] [Related]
75. Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence. Kim SC; Oh MM J Urol; 1992 Jun; 147(6):1530-2. PubMed ID: 1593682 [TBL] [Abstract][Full Text] [Related]
76. Intracavernous injections for impotence. Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212 [No Abstract] [Full Text] [Related]
80. Evaluation of I-C papaverine in patients with psychogenic and organic impotence. Cooper AJ Can J Psychiatry; 1991 Oct; 36(8):574-8. PubMed ID: 1742710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]